Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double‐blind placebo‐controlled study

This study evaluated the efficacy and safety of tadalafil in pediatric patients with pulmonary arterial hypertension. This phase‐3, international, randomized, multicenter (24 weeks double‐blind placebo‐controlled period; two‐year, open‐labeled extension period), add‐on (patient’s current endothelin...

詳細記述

書誌詳細

出版年:	Pulmonary Circulation
主要な著者:	Dunbar Ivy, Damien Bonnet, Rolf Berger, Gisela M.B. Meyer, Simin Baygani, Baohui Li, the LVHV Study Group
フォーマット:	論文
言語:	英語
出版事項:	Wiley 2021-07-01
主題:	pulmonary arterial hypertension hypertension pulmonary biomarkers risk factors
オンライン･アクセス:	https://doi.org/10.1177/20458940211024955